Aquestive Therapeutics Inc. (AQST)
NASDAQ
Aquestive Therapeutics Inc. Cash on Hand 2017–2025
Aquestive Therapeutics Inc. annual cash on hand history from 2017 to 2025. Cash on hand refers to the total amount of cash and cash equivalents held by a company.
- Aquestive Therapeutics Inc. cash on hand as of December 31, 2025: 121.2M, a 69.36% increase year-over-year.
- Aquestive Therapeutics Inc. cash on hand for 2025 were 121.2M, a 69.36% increase from 2024.
- Aquestive Therapeutics Inc. cash on hand for 2024 were 71.5M, a 199.71% increase from 2023.
- Aquestive Therapeutics Inc. cash on hand for 2023 were 23.9M, a 12.47% decrease from 2022.
- Aquestive Therapeutics Inc. cash on hand for 2022 were 27.3M.
Cash on Hand
ANNUAL · $B
YEAR-OVER-YEAR GROWTH · %
| Aquestive Therapeutics Inc. Annual Cash on Hand (Millions of US $) | |
|---|---|
| 2025 | $121 |
| 2024 | $72 |
| 2023 | $24 |
| 2022 | $27 |
| 2021 | $28 |
| 2020 | $32 |
| 2019 | $49 |
| 2018 | $61 |
| 2017 | $17 |
Aquestive Therapeutics Inc. Cash on Hand — FAQ
Aquestive Therapeutics Inc. (AQST) cash on hand over the last 9 years — annual and quarterly figures with year-over-year growth and charts.
Where can I see AQST's cash on hand history?
The chart and table above show Aquestive Therapeutics Inc.'s cash on hand by year and by quarter, including the growth rate.